Cargando…
Liver-targeted delivery of asiatic acid nanostructured lipid carrier for the treatment of liver fibrosis
Liver fibrosis is a major global health concern. Management of chronic liver disease is severely restricted in clinics due to ineffective treatment approaches. However, a lack of targeted therapy may aggravate this condition. Asiatic acid (AA), a pentacyclic triterpenoid acid, can effectively protec...
Autores principales: | Zhang, Ya-Wen, Tu, Ling-Lan, Zhang, Yi, Pan, Jie-Chao, Zheng, Gao-Li, Yin, Li-Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648005/ https://www.ncbi.nlm.nih.gov/pubmed/34854788 http://dx.doi.org/10.1080/10717544.2021.2008054 |
Ejemplares similares
-
Nanostructured lipid carriers for MicroRNA delivery in tumor gene therapy
por: Wang, Hairong, et al.
Publicado: (2018) -
Asiatic Acid Inhibits Liver Fibrosis by Blocking TGF-beta/Smad Signaling In Vivo and In Vitro
por: Tang, Li-xia, et al.
Publicado: (2012) -
Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery
por: Lin, Yin-Ku, et al.
Publicado: (2010) -
Nanostructured lipid carriers: versatile oral delivery vehicle
por: Poonia, Neelam, et al.
Publicado: (2016) -
Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review
por: Haider, Mohamed, et al.
Publicado: (2020)